Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses

Clinica Chimica Acta

Volumn 389, Issue 1-2, 2008, Pages 126-131

  Nagy, Bálint ^a   Savli, Hakan ^b   Molvarec, Attila ^a   Várkonyi, Tibor ^a   Rigó, Barbara ^a   Hupuczi, Petronella ^a   Rigó Jr , János ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b KOCAELI UNIVERSITY   (Turkey)

Author keywords

HELLP syndrome; Melting curve analysis; Preeclampsia; Real time PCR; SNP; VEGF

Indexed keywords

VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; DNA ISOLATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENOTYPE; HELLP SYNDROME; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; FEMALE; HELLP SYNDROME; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38649114682     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.12.003     Document Type: Article

References (33)

1. A.L. Tranquilli, B. Landi, A. Corradetti, et al. Inflammatory cytokines patterns in the placenta of pregnancies complicated by HELLP (hemolysis, elevated liver enzyme, and low platelet) syndrome. Cytokine in press.
2. Nagy B., Hupuczi P., and Papp Z. High frequency of methylenetetrahydrofolate reductase 677TT genotype in Hungarian HELLP syndrome patients determined by quantitative real-time PCR. J Hum Hypertension 21 (2007) 154-158
3. Greer I.A. Thrombosis in pregnancy: maternal and fetal issues. Lancet 353 (1999) 1258-1265
4. Kupferminc M.J. Thrombophilia and pregnancy. Reprod Biol Endocrinol 1 (2003) 111-133
5. Kupferminc M.J. Thrombophilia and preeclampsia: the evidence so far. Clin Obstet Gynecol 48 (2005) 406-415
6. Lachmeijer A.M., Arngrimsson R., Bastiaans E.J., et al. Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels, and vitamin status in women with a history of preeclampsia. Am J Obstet Gynecol 184 (2001) 394-402
7. Lachmeijer A.M., Dekker G.A., Pals G., et al. Searching for preeclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol 105 (2002) 94-113
8. Nagy B., Rigo J., Fintor L., et al. Distribution of apolipoprotein(a) isoforms in normotensive and severe preeclamptic women. J Mat Fetal Med 8 (1999) 270-274
9. Nagy B., Toth T., Rigo J., et al. Detection of factor V Leiden mutation in severe preeclamptic Hungarian women. Clin Genet 53 (1998) 478-491
10. Rigo Jr. J., Nagy B., Fintor L., et al. Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase. Hypertens Pregnancy 19 (2001) 163-172
11. Dekker G.A., and Sibai B.M. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 179 (1998) 1359-1375
12. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
13. Gargett C.E., and Rogers P.A. Human endometrial angiogenesis. Reproduction 121 (2001) 181-186
14. Vincenti V., Cassano C., Rocchi M., et al. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93 (1996) 1493-1495
15. Brogan I.J., Khan N., and Isaac K. Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 60 (1999) 1245-1249
16. Awata T., Inoue K., Kurihara S., et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51 (2002) 1635-1639
17. Renner W., Kotschan S., Hoffmann C., et al. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37 (2000) 443-448
18. Papazoglou D., Galazios G., Koukourakis I.M., et al. Vascular endothelial growth factor gene polymorphisms and pre-eclampsia. Mol Hum Reprod 5 (2004) 321-324
19. Bányász I., Szabó S.z., Bokodi Á., et al. Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia. Mol Hum Reprod 4 (2006) 233-236
20. Shim J.Y., Jun J.K., Jung B.K., et al. Vascular endothelial growth factor gene +936 C/T polymorphism is associated with preeclampsia in Korean women. Am J Obstet Gynecol 197 (2007) e1-e4 271
21. Watson CJ, Webb NJ, Bottomley MJ, et al. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 200;12:1232-35.
22. Shahbazi M., Fryer A.A., Pravica V., et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13 (2002) 260-264
23. Stevens A., Soden J., Brenchley P.E., et al. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 63 (2003) 812-816
24. Baker P.N., Krasnow J., Roberts J.M., et al. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 86 (1995) 815-821
25. Kupferminc M.J., Daniel Y., Englender T., et al. Vascular endothelial growth factor is increased in patients with preeclampsia. Am J Reprod Immunol 38 (1997) 302-306
26. Hunter A., Aitkenhead M., Caldwell C., et al. Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension 36 (2000) 965-969
27. Lyall F, Greer IA, Boswell F, et al. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and preeclampsia. 1997;104,223-228.
28. Maynard S.E., Min J.Y., Merchan J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003) 649-658
29. Levine R.J., Maynard S.E., Qian C., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004) 672-683
30. Hertig A., Berkane N., Lefevre G., et al. Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. Clin Chem 50 (2004) 1702-1703
31. Zhou Y., McMaster M., Woo K., et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160 (2002) 1405-1423
32. Baumwell S., and Karumanchi S.A. Pre-eclampsia: clinical manifestations and molecular mechanisms. Nephron Clin Pract 106 (2007) c72-c81
33. Karumanchi A.S., Masnard S.E., Stillman I.E., et al. Preeclampsia: a renal perspective. Kindey Internat 67 (2005) 2101-2213